Impact Biomedical IBO
NYSE IBO
$5.32 -0.14 (-2.56%)
At close: Oct 2, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Change in Accured Expenses (2022 - 2026)

Updated

Impact Biomedical (IBO) reported Change in Accured Expenses of $38,000 for Q2 2026, down 35.6% from $59,000 a year earlier but up 137.5% from the prior quarter.

Analysis

Impact Biomedical (IBO) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Impact Biomedical's Change in Accured Expenses came in at -$19,000; for FY2025, it was -$2,000.

  • By year, Change in Accured Expenses came in at -$35,000 in FY2024, $167,000 in FY2023 (+193.0%) and $57,000 in FY2022.
  • Five-year quarterly Change in Accured Expenses spans a low of -$183,000 in Q1 2024 and a high of $224,000 in Q4 2023.
  • Year over year, Change in Accured Expenses gained in four of the last six quarters, with growth averaging 152.1%.
  • The high point for year-over-year Change in Accured Expenses in five years was Q3 2024 (growth of 583.3%); the low point was Q4 2024 (a decline of 58.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $16,000 (Q1 2026), -$142,000 (Q4 2025) and $69,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Impact Biomedical 573.61 Mn 576.81 Mn 2,000.00 38,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38,000.00
Mar 31, 2026 16,000.00
Dec 31, 2025 -142,000.00
Sep 30, 2025 69,000.00
Jun 30, 2025 59,000.00
Mar 31, 2025 12,000.00
Dec 31, 2024 93,000.00
Sep 30, 2024 41,000.00
Jun 30, 2024 14,000.00
Mar 31, 2024 -183,000.00
Dec 31, 2023 224,000.00
Sep 30, 2023 6,000.00
Jun 30, 2023 -50,000.00
Mar 31, 2023 -13,000.00
Dec 31, 2022 51,000.00
Sep 30, 2022 7,000.00
API Access

Impact Biomedical Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY